Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6145009 | American Journal of Obstetrics and Gynecology | 2016 | 6 Pages |
Abstract
Cerclage placement or administration of 17OHP-C therapy for midtrimester short cervix for PTD prevention appears beneficial only in the subset of patients with high inflammation. Knowledge of the amniotic fluid inflammatory status may aid in guiding the appropriate therapy for women presenting with midtrimester short cervix who are at increased risk of PTD.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Daniel G. MD, Morgan R. PhD, Sean M. MD, Orion MD, Cande V. PhD, Anthony M. MD, Nazeeh MD,